 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-13-2023
Insider Buy |
Bertrand Velge
Director |
$2.49
CAGR »
|
$183,922.10
73,965 shares |
6-14-2023
Insider Buy |
Bertrand Velge
Director |
$2.94
CAGR »
|
$11,579.76
3,945 shares |
6-14-2023
Insider Buy |
Nicholas P. Alvarez
Chief Acquisition Officer |
$2.92
CAGR »
|
$31,279.04
10,712 shares |
6-13-2023
Insider Buy |
Bertrand Velge
Director |
$2.48
CAGR »
|
$170,480.03
68,865 shares |
6-13-2023
Insider Buy |
Eric Harold Yecies
General Counsel & CCO |
$2.60
CAGR »
|
$29,900.00
11,500 shares |
6-6-2023
Insider Buy |
Bertrand Velge
Director |
$2.18
CAGR »
|
$303,877.82
139,500 shares |
5-23-2023
Insider Buy |
Stefan Galluppi
Chief Innovation Officer |
$2.17
CAGR »
|
$9,999.36
4,608 shares |
5-26-2023
Insider Buy |
Brad Michael Roberts
Chief Operating Officer |
$2.19
CAGR »
|
$65,706.00
30,000 shares |
5-23-2023
Insider Buy |
Justin Schreiber
CEO |
$2.09
CAGR »
|
$104,625.09
50,000 shares |
5-18-2022
Insider Buy |
Naveen Bhatia
Director |
$2.14
CAGR »
|
$106,800.00
50,000 shares |
3-14-2022
Insider Buy |
Eric Harold Yecies
General Counsel & CCO |
$3.14
CAGR »
|
$15,700.00
5,000 shares |
3-10-2022
Insider Buy |
Joseph Ditrolio
Director |
$3.28
CAGR »
|
$6,560.00
2,000 shares |
12-7-2021
Insider Buy |
Bertrand Velge
Director |
$4.54
CAGR »
|
$113,500.00
25,000 shares |
12-1-2021
Insider Buy |
Naveen Bhatia
Director |
$4.26
CAGR »
|
$213,165.00
50,000 shares |
11-30-2021
Insider Buy |
Marc David Benathen
Chief Financial Officer |
$4.09
CAGR »
|
$32,028.79
7,831 shares |
11-30-2021
Insider Buy |
Naveen Bhatia
Director |
$3.88
CAGR »
|
$193,800.00
50,000 shares |
11-23-2021
Insider Buy |
Eric Harold Yecies
CCO and General Counsel |
$4.12
CAGR »
|
$30,488.00
7,400 shares |
11-18-2021
Insider Buy |
Joseph Ditrolio
Director |
$4.89
CAGR »
|
$9,780.00
2,000 shares |
11-17-2021
Insider Buy |
Stefan Galluppi
Chief Technology Officer |
$4.80
CAGR »
|
$8,874.82
1,848 shares |
11-15-2021
Insider Buy |
Stefan Galluppi
Chief Technology Officer |
$4.55
CAGR »
|
$9,995.35
2,197 shares |
9-14-2021
Insider Buy |
Happy David Walters
|
$7.19
CAGR »
|
$299,655.49
41,697 shares |
8-25-2021
Insider Buy |
Corey Deutsch
Chief Business Officer |
$7.69
CAGR »
|
$49,240.96
6,400 shares |
8-23-2021
Insider Buy |
Corey Deutsch
Chief Business Officer |
$7.37
CAGR »
|
$29,474.80
4,000 shares |
8-18-2021
Insider Buy |
Joseph Ditrolio
Director |
$6.78
CAGR »
|
$13,566.40
2,000 shares |
8-18-2021
Insider Buy |
Marc David Benathen
Chief Financial Officer |
$7.27
CAGR »
|
$22,286.48
3,067 shares |
8-18-2021
Insider Buy |
Corey Deutsch
Chief Business Officer |
$6.82
CAGR »
|
$81,799.20
12,000 shares |
5-19-2021
Insider Buy |
Marc David Benathen
Chief Financial Officer |
$8.91
CAGR »
|
$12,609.72
1,416 shares |
5-19-2021
Insider Buy |
Eric Harold Yecies
CCO and General Counsel |
$9.24
CAGR »
|
$102,564.00
11,100 shares |
5-19-2021
Insider Buy |
Corey Deutsch
Chief Business Officer |
$8.85
CAGR »
|
$199,470.15
22,539 shares |
2-25-2021
Insider Buy |
Brad Michael Roberts
Chief Operating Officer |
$20.50
CAGR »
|
$102,500.00
5,000 shares |
2-25-2021
Insider Buy |
Eric Harold Yecies
Chief Compliance Officer |
$20.08
CAGR »
|
$100,400.00
5,000 shares |
Also See: Institutional Holders of LFMD
Also See: SEC filings
Below we present the annualized performance delivered by LifeMD stock since 6-13-2023 (the date of the most recent
insider purchase). The performance of the investment from the time LifeMD insider buying occurred is the ultimate
test of whether insiders were right about LFMD being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/14/2023 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$2.98 |
|
| End price/share: |
$11.95 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
301.01% |
|
| Annualized Gain: |
346.59% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$40,101.00 |
|
| Years: |
0.87 |
|
LifeMD Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent LifeMD insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding LFMD
|
|
Free LFMD Email Alerts:
